Values First Advisors, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Values First Advisors, Inc.

$169 Million
Q1 2024

A detailed history of Values First Advisors, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 7,738 shares of ALNY stock, worth $1.94 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

7,738

Previous 6,983 10.81%

Holding current value

$1.94 Million

Previous $1.34 Million 13.47%

% of portfolio

0.68%

Previous 0.81%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$146.51 - $198.2 $110,615 - $149,641	755 Added 10.81%	7,738 $1.16 Million
Q4 2023 Jan 18, 2024	BUY	$151.41 - $196.57 $72,071 - $93,567	476 Added 7.32%	6,983 $1.34 Million
Q3 2023 Nov 08, 2023	SELL	$170.77 - $211.65 $8,538 - $10,582	-50 Reduced 0.76%	6,507 $1.15 Million
Q2 2023 Aug 02, 2023	BUY	$185.01 - $212.05 $27,011 - $30,959	146 Added 2.28%	6,557 $1.25 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $19,909 - $25,672	109 Added 1.73%	6,411 $1.28 Million

Q4 2022 Jan 20, 2023	BUY	$185.53 - $241.31 $6,493 - $8,445	35 Added 0.56%	6,302 $0
Q3 2022 Dec 02, 2022	BUY	$138.54 - $232.0 $27,846 - $46,632	201 Added 3.31%	6,267 $1.25 Million
Q2 2022 Jul 20, 2022	SELL	$120.42 - $169.29 $51,780 - $72,794	-430 Reduced 6.62%	6,066 $885,000
Q1 2022 May 03, 2022	BUY	$127.18 - $173.91 $44,131 - $60,346	347 Added 5.64%	6,496 $1.06 Million
Q4 2021 Mar 10, 2022	BUY	$159.56 - $209.29 $981,134 - $1.29 Million	6,149 New	6,149 $1.04 Million
Q3 2021 Nov 15, 2022	BUY	$169.75 - $207.73 $76,557 - $93,686	451 Added 7.43%	6,517 $1.23 Million
Q2 2021 Nov 15, 2022	SELL	$128.63 - $176.89 $16,721 - $22,995	-130 Reduced 2.02%	6,304 $1.07 Million
Q1 2021 Nov 15, 2022	BUY	$126.83 - $175.69 $46,673 - $64,653	368 Added 6.07%	6,434 $908,000
Q4 2020 Nov 15, 2022	SELL	$122.97 - $147.0 $24,471 - $29,253	-199 Reduced 3.05%	6,335 $823,000
Q3 2020 Nov 15, 2022	BUY	$121.19 - $165.49 $40,113 - $54,777	331 Added 5.34%	6,534 $951,000
Q2 2020 Nov 15, 2022	BUY	$104.21 - $156.44 $23,030 - $34,573	221 Added 3.69%	6,203 $919,000
Q1 2020 Jan 09, 2023	BUY	$93.12 - $133.99 $7,635 - $10,987	82 Added 1.31%	6,349 $691 Million
Q4 2019 Nov 15, 2022	SELL	$74.51 - $124.23 $6,258 - $10,435	-84 Reduced 1.38%	5,982 $689,000

Others Institutions Holding ALNY

# of Institutions

585

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Account

Values First Advisors, Inc. Alnylam Pharmaceuticals, Inc. Transaction History